Farrell Mitchell R, Ye Qiying, Xie Yiyan, Esteban Jeanine Sandra D, Mahler Stephen V
University of California, Irvine Department of Neurobiology and Behavior, 1203 McGaugh Hall Irvine, CA, 92697, USA.
Addict Neurosci. 2022 Sep;3. doi: 10.1016/j.addicn.2022.100026. Epub 2022 Jun 30.
Opioid addiction is a chronic, relapsing disorder. Whether addicted individuals are forced to abstain or they decide themselves to quit using drugs, relapse rates are high-especially upon encountering contexts and stimuli associated with prior opioid use. Rodents similarly show context- and cue-induced reinstatement of drug seeking following abstinence, and intriguingly, the neural circuits underlying these relapse-like behaviors differ when abstinence is involuntarily imposed, responding is extinguished, or animals decide themselves to cease taking drug. Here, we employ two complementary rat behavioral models of relapse-like behavior for the highly reinforcing opioid drug remifentanil, and asked whether GABAergic neurons in the ventral pallidum (VP) control opioid seeking under these behavioral conditions. Specifically, we asked how chemogenetically stimulating VP neurons with clozapine-N-oxide (CNO) influences the ability of contextual or discrete remifentanil-paired cues to reinstate drug seeking following either voluntary abstinence (punishment-induced; Group), or extinction training (Group). In Group rats, we also chemogenetically inhibited VP neurons, and examined spontaneous VP activity (Fos) during cued reinstatement. In both Group and Group rats, stimulating Gq-signaling in VP neurons augmented remifentanil reinstatement in a cue- and context-dependent manner. Conversely, engaging inhibitory Gi-signaling in VP neurons in Group suppressed cue-induced reinstatement, and cue-triggered seeking was correlated with Fos expression in rostral, but not caudal VP. Neither stimulating nor inhibiting VP neurons influenced unpunished remifentanil self-administration. We conclude that VP neurons bidirectionally control opioid seeking regardless of the specific relapse model employed, highlighting their fundamental role in opioid relapse-like behavior across behavioral models, and potentially across species.
阿片类药物成瘾是一种慢性复发性疾病。无论成瘾者是被迫戒断还是自行决定戒毒,复发率都很高,尤其是在遇到与先前使用阿片类药物相关的环境和刺激时。啮齿动物在戒断后同样会出现环境和线索诱导的觅药行为恢复,有趣的是,当戒断是被迫的、反应被消退或动物自行决定停止用药时,这些类似复发行为背后的神经回路是不同的。在这里,我们采用了两种互补的大鼠类似复发行为的模型来研究强效阿片类药物瑞芬太尼,并询问腹侧苍白球(VP)中的γ-氨基丁酸能神经元在这些行为条件下是否控制阿片类药物的觅药行为。具体来说,我们研究了用氯氮平N-氧化物(CNO)对VP神经元进行化学遗传刺激如何影响情境或离散的瑞芬太尼配对线索在自愿戒断(惩罚诱导;组)或消退训练(组)后恢复觅药行为的能力。在组大鼠中,我们还对VP神经元进行化学遗传抑制,并在线索诱导的恢复过程中检查自发的VP活动(Fos)。在组和组大鼠中,刺激VP神经元中的Gq信号以线索和环境依赖的方式增强了瑞芬太尼的恢复。相反,在组中激活VP神经元中的抑制性Gi信号抑制了线索诱导的恢复,并且线索触发的觅药行为与吻侧而非尾侧VP中的Fos表达相关。刺激或抑制VP神经元均不影响未受惩罚的瑞芬太尼自我给药。我们得出结论,无论采用何种具体的复发模型,VP神经元都能双向控制阿片类药物的觅药行为,突出了它们在跨行为模型以及可能跨物种的阿片类药物复发样行为中的基本作用。